Safety of implantable contraceptives for women: data from observational studies

被引:11
作者
Curtis, KM [1 ]
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Reprod Hlth, Atlanta, GA 30333 USA
关键词
contraception; implants; safety; levonorgestrel; etonogestrel;
D O I
10.1016/S0010-7824(01)00291-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Contraceptive implants are registered in over 60 countries and have been used by millions of women for three decades. This article reviews findings from observational studies on the safety of contraceptive implants and examines the risk of specific health outcomes. Fifty-five articles were reviewed, and the body of evidence for each health outcome was summarized. Available evidence suggests that contraceptive implants are safe and, overall, implant users do not experience adverse events at rates higher than women not using implants. With respect to specific outcomes, the evidence suggests no increased risks of pelvic inflammatory disease, decreased bone mineral density, anemia, thrombocytopenia. or death with implant use. The evidence was too limited to draw meaningful conclusions for neoplastic disease, cardiovascular events, and HIV/AIDS. Nonsignificantly elevated associations were reported for diabetes, serious mental disorders, and rheumatoid arthritis. Conditions for which risks were marginally, yet significantly, elevated were hypertension and gall bladder disease. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:85 / 96
页数:12
相关论文
共 64 条
[1]  
ADEDEVOH K, 1985, B WORLD HEALTH ORGAN, V63, P485
[2]   RETRACTED: A pilot efficacy study with a single-rod contraceptive implant (Implanon®) in 200 Indonesian women treated for ≤4 years (Retracted Article) [J].
Affandi, B ;
Korver, T ;
Geurts, TBP ;
Bennink, HJTC .
CONTRACEPTION, 1999, 59 (03) :167-174
[3]   A 5-YEAR CLINICAL-EVALUATION OF NORPLANT(R) CONTRACEPTIVE SUBDERMAL IMPLANTS IN BANGLADESHI ACCEPTORS [J].
AKHTER, H ;
DUNSON, TR ;
AMATYA, RN ;
BEGUM, K ;
CHOWDHURY, T ;
DIGHE, N ;
KRUEGER, SL ;
RAHMAN, S .
CONTRACEPTION, 1993, 47 (06) :569-582
[4]  
[Anonymous], BR J FAM PLANN
[5]  
BALA Y, 1991, Advances in Contraception, V7, P77, DOI 10.1007/BF01850721
[6]   THE EFFECTS OF NOMEGESTROL ACETATE SUBDERMAL IMPLANT (UNIPLANT) ON CARBOHYDRATE-METABOLISM, SERUM-LIPOPROTEINS AND ON HEPATIC-FUNCTION IN WOMEN [J].
BARBOSA, I ;
COUTINHO, E ;
ATHAYDE, C ;
LADIPO, O ;
OLSSON, SE ;
ULMSTEN, U .
CONTRACEPTION, 1995, 52 (02) :111-114
[7]   Bone mineral density during long-term use of the progestagen contraceptive implant Implanon® compared to a non-hormonal method of contraception [J].
Beerthuizen, R ;
van Beek, A ;
Massai, R ;
Mäkäräinen, L ;
in't Hout, J ;
Bennink, HC .
HUMAN REPRODUCTION, 2000, 15 (01) :118-122
[8]   Nonmenstrual adverse events during use of implantable contraceptives for women: data from clinical trials [J].
Brache, V ;
Faundes, A ;
Alvarez, F ;
Cochon, L .
CONTRACEPTION, 2002, 65 (01) :63-74
[9]   Five-year evaluation of safety, efficacy and acceptability of Norplant implants in Nepal [J].
Chetri, M ;
Bhatta, A ;
Amatya, RN ;
Lama, H ;
Dunson, TR ;
Spivey, S ;
McMahan, JH ;
Balogh, S .
ADVANCES IN CONTRACEPTION, 1996, 12 (03) :187-199
[10]   Multicenter clinical trial on the efficacy and acceptability of a single contraceptive implant of nomegestrol acetate, Uniplant [J].
Coutinho, EM ;
deSouza, JC ;
Athayde, C ;
Barbosa, IC ;
Alvarez, F ;
Brache, V ;
Gu, ZP ;
Emuveyan, EE ;
Adekunle, AO ;
Devoto, L ;
Shaaban, MM ;
Salem, HT ;
Affandi, B ;
deAcosta, OM ;
Mati, J ;
Ladipo, OA .
CONTRACEPTION, 1996, 53 (02) :121-125